Study: Weekly exenatide as effective as daily diabetes treatments

01/18/2012 | Medscape (free registration)

A study in Diabetes Care of 820 drug-naive patients with type 2 diabetes found that absolute changes in A1C levels were -1.53% in those who had once-weekly exenatide, -1.48% with daily metformin, -1.63% with daily pioglitazone and -1.15% with daily sitagliptin. The researchers said weight changes were -2.0 kg with exenatide once weekly and metformin, +1.5 kg with pioglitazone and -0.8 kg with sitagliptin.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations